메뉴 건너뛰기




Volumn 14, Issue 3, 2012, Pages

Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRASTUZUMAB; ANTIBODY; CANCER VACCINE; ERBB2 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

EID: 84861880890     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3204     Document Type: Article
Times cited : (32)

References (47)
  • 1
    • 34548066097 scopus 로고    scopus 로고
    • An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands [review]
    • Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R: An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands [review]. Int J Mol Med. 2007, 20: 3. 10.
    • (2007) Int J Mol Med , vol.20 , pp. 3-10
    • Ferrer-Soler, L.1    Vazquez-Martin, A.2    Brunet, J.3    Menendez, J.A.4    De Llorens, R.5    Colomer, R.6
  • 3
    • 73649149433 scopus 로고    scopus 로고
    • Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models
    • Scheuer W, Friess T, Burtscher H, Bossenmaier B, Endl J, Hasmann M: Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 2009, 69: 9330-9336. 10.1158/0008-5472.CAN-08-4597.
    • (2009) Cancer Res , vol.69 , pp. 9330-9336
    • Scheuer, W.1    Friess, T.2    Burtscher, H.3    Bossenmaier, B.4    Endl, J.5    Hasmann, M.6
  • 4
    • 77949903478 scopus 로고    scopus 로고
    • Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy
    • Baselga J, Gelmon KA, Verma S, Wardley A, Conte P, Miles D, Bianchi G, Cortes J, McNally VA, Ross GA, Fumoleau P, Gianni L: Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J Clin Oncol. 2010, 28: 1138-1144. 10.1200/JCO.2009.24.2024.
    • (2010) J Clin Oncol , vol.28 , pp. 1138-1144
    • Baselga, J.1    Gelmon, K.A.2    Verma, S.3    Wardley, A.4    Conte, P.5    Miles, D.6    Bianchi, G.7    Cortes, J.8    McNally, V.A.9    Ross, G.A.10    Fumoleau, P.11    Gianni, L.12
  • 5
    • 34547871259 scopus 로고    scopus 로고
    • Targeting HER proteins in cancer therapy and the role of the non-target HER3
    • Hsieh AC, Moasser MM: Targeting HER proteins in cancer therapy and the role of the non-target HER3. Br J Cancer. 2007, 97: 453-457. 10.1038/sj.bjc.6603910.
    • (2007) Br J Cancer , vol.97 , pp. 453-457
    • Hsieh, A.C.1    Moasser, M.M.2
  • 6
    • 34547854801 scopus 로고    scopus 로고
    • The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
    • Moasser MM: The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene. 2007, 26: 6469-6487. 10.1038/sj.onc.1210477.
    • (2007) Oncogene , vol.26 , pp. 6469-6487
    • Moasser, M.M.1
  • 7
    • 0348049831 scopus 로고    scopus 로고
    • Mechanisms controlling EGF receptor endocytosis and degradation
    • Dikic I: Mechanisms controlling EGF receptor endocytosis and degradation. Biochem Soc Trans. 2003, 31: 1178-1181. 10.1042/BST0311178.
    • (2003) Biochem Soc Trans , vol.31 , pp. 1178-1181
    • Dikic, I.1
  • 8
    • 0037429692 scopus 로고    scopus 로고
    • Trafficking of the ErbB receptors and its influence on signaling
    • Wiley HS: Trafficking of the ErbB receptors and its influence on signaling. Exp Cell Res. 2003, 284: 78-88. 10.1016/S0014-4827(03)00002-8.
    • (2003) Exp Cell Res , vol.284 , pp. 78-88
    • Wiley, H.S.1
  • 9
    • 25844457433 scopus 로고    scopus 로고
    • The epidermal growth factor receptor family
    • Bazley LA, Gullick WJ: The epidermal growth factor receptor family. Endocr Relat Cancer. 2005, 12 (Suppl 1): S17-S27.
    • (2005) Endocr Relat Cancer , vol.12 , pp. S17-S27
    • Bazley, L.A.1    Gullick, W.J.2
  • 10
    • 54849372300 scopus 로고    scopus 로고
    • Endocytosis and intracellular trafficking of ErbBs
    • Sorkin A, Goh LK: Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res. 2008, 314: 3093-3106.
    • (2008) Exp Cell Res , vol.314 , pp. 3093-3106
    • Sorkin, A.1    Goh, L.K.2
  • 12
    • 0036083843 scopus 로고    scopus 로고
    • EGF receptor downregulation depends on a trafficking motif in the distal tyrosine kinase domain
    • Jones SM, Foreman SK, Shank BB, Kurten RC: EGF receptor downregulation depends on a trafficking motif in the distal tyrosine kinase domain. Am J Physiol Cell Physiol. 2002, 282: C420-C433.
    • (2002) Am J Physiol Cell Physiol , vol.282 , pp. C420-C433
    • Jones, S.M.1    Foreman, S.K.2    Shank, B.B.3    Kurten, R.C.4
  • 14
    • 0036132653 scopus 로고    scopus 로고
    • Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA
    • Piechocki MP, Pilon SA, Wei WZ: Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA. J Immunol Methods. 2002, 259: 33-42. 10.1016/S0022-1759(01)00487-2.
    • (2002) J Immunol Methods , vol.259 , pp. 33-42
    • Piechocki, M.P.1    Pilon, S.A.2    Wei, W.Z.3
  • 15
    • 13444252597 scopus 로고    scopus 로고
    • Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors
    • Yang XL, Huang YZ, Xiong WC, Mei L: Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors. Mol Cell Neurosci. 2005, 28: 335-346. 10.1016/j.mcn.2004.10.001.
    • (2005) Mol Cell Neurosci , vol.28 , pp. 335-346
    • Yang, X.L.1    Huang, Y.Z.2    Xiong, W.C.3    Mei, L.4
  • 17
    • 0025964104 scopus 로고
    • The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain
    • Akiyama T, Matsuda S, Namba Y, Saito T, Toyoshima K, Yamamoto T: The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain. Mol Cell Biol. 1991, 11: 833-842.
    • (1991) Mol Cell Biol , vol.11 , pp. 833-842
    • Akiyama, T.1    Matsuda, S.2    Namba, Y.3    Saito, T.4    Toyoshima, K.5    Yamamoto, T.6
  • 18
    • 0027984771 scopus 로고
    • NIH/3T3 cells transformed with the activated erbB-2 oncogene can be phenotypically reverted by a kinase deficient, dominant negative erbB-2 variant
    • Messerle K, Schlegel J, Hynes NE, Groner B: NIH/3T3 cells transformed with the activated erbB-2 oncogene can be phenotypically reverted by a kinase deficient, dominant negative erbB-2 variant. Mol Cell Endocrinol. 1994, 105: 1. 10. 10.1016/0303-7207(94)90029-9.
    • (1994) Mol Cell Endocrinol , vol.105 , pp. 1-10
    • Messerle, K.1    Schlegel, J.2    Hynes, N.E.3    Groner, B.4
  • 19
    • 0028229715 scopus 로고
    • A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway
    • Ben-Levy R, Paterson HF, Marshall CJ, Yarden Y: A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J. 1994, 13: 3302-3311.
    • (1994) EMBO J , vol.13 , pp. 3302-3311
    • Ben-Levy, R.1    Paterson, H.F.2    Marshall, C.J.3    Yarden, Y.4
  • 20
    • 0032952692 scopus 로고    scopus 로고
    • Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA
    • Wei WZ, Shi WP, Galy A, Lichlyter D, Hernandez S, Groner B, Heilbrun L, Jones RF: Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA. Int J Cancer. 1999, 81: 748-754. 10.1002/(SICI)1097-0215(19990531)81:5<748::AID-IJC14>3.0.CO;2-6.
    • (1999) Int J Cancer , vol.81 , pp. 748-754
    • Wei, W.Z.1    Shi, W.P.2    Galy, A.3    Lichlyter, D.4    Hernandez, S.5    Groner, B.6    Heilbrun, L.7    Jones, R.F.8
  • 21
    • 0025354081 scopus 로고
    • The role of autophosphorylation in modulation of erbB-2 transforming function
    • Segatto O, Lonardo F, Pierce JH, Bottaro DP, Di Fiore PP: The role of autophosphorylation in modulation of erbB-2 transforming function. New Biol. 1990, 2: 187-195.
    • (1990) New Biol , vol.2 , pp. 187-195
    • Segatto, O.1    Lonardo, F.2    Pierce, J.H.3    Bottaro, D.P.4    Di Fiore, P.P.5
  • 22
    • 0032860819 scopus 로고    scopus 로고
    • Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers
    • Muthuswamy SK, Gilman M, Brugge JS: Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol Cell Biol. 1999, 19: 6845-6857.
    • (1999) Mol Cell Biol , vol.19 , pp. 6845-6857
    • Muthuswamy, S.K.1    Gilman, M.2    Brugge, J.S.3
  • 24
    • 65349101151 scopus 로고    scopus 로고
    • Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941
    • Junttila TT, Akita RW, Parsons K, Fields C, Lewis Phillips GD, Friedman LS, Sampath D, Sliwkowski MX: Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941. Cancer Cell. 2009, 15: 429-440. 10.1016/j.ccr.2009.03.020.
    • (2009) Cancer Cell , vol.15 , pp. 429-440
    • Junttila, T.T.1    Akita, R.W.2    Parsons, K.3    Fields, C.4    Lewis Phillips, G.D.5    Friedman, L.S.6    Sampath, D.7    Sliwkowski, M.X.8
  • 26
    • 78650487946 scopus 로고    scopus 로고
    • HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer
    • Gijsen M, King P, Perera T, Parker PJ, Harris AL, Larijani B, Kong A: HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol. 2010, 8: e1000563. 10.1371/journal.pbio.1000563.
    • (2010) PLoS Biol , vol.8
    • Gijsen, M.1    King, P.2    Perera, T.3    Parker, P.J.4    Harris, A.L.5    Larijani, B.6    Kong, A.7
  • 29
    • 0030968648 scopus 로고    scopus 로고
    • Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu
    • Worthylake R, Wiley HS: Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu. J Biol Chem. 1997, 272: 8594-8601. 10.1074/jbc.272.13.8594.
    • (1997) J Biol Chem , vol.272 , pp. 8594-8601
    • Worthylake, R.1    Wiley, H.S.2
  • 30
    • 0033605560 scopus 로고    scopus 로고
    • ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors
    • Worthylake R, Opresko LK, Wiley HS: ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors. J Biol Chem. 1999, 274: 8865-8874. 10.1074/jbc.274.13.8865.
    • (1999) J Biol Chem , vol.274 , pp. 8865-8874
    • Worthylake, R.1    Opresko, L.K.2    Wiley, H.S.3
  • 31
    • 0026519802 scopus 로고
    • Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density
    • Kornilova ES, Taverna D, Hoeck W, Hynes NE: Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density. Oncogene. 1992, 7: 511-519.
    • (1992) Oncogene , vol.7 , pp. 511-519
    • Kornilova, E.S.1    Taverna, D.2    Hoeck, W.3    Hynes, N.E.4
  • 32
    • 18544383164 scopus 로고    scopus 로고
    • Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4
    • Katz M, Shtiegman K, Tal-Or P, Yakir L, Mosesson Y, Harari D, Machluf Y, Asao H, Jovin T, Sugamura K, Yarden Y: Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4. Traffic. 2002, 3: 740-751. 10.1034/j.1600-0854.2002.31006.x.
    • (2002) Traffic , vol.3 , pp. 740-751
    • Katz, M.1    Shtiegman, K.2    Tal-Or, P.3    Yakir, L.4    Mosesson, Y.5    Harari, D.6    Machluf, Y.7    Asao, H.8    Jovin, T.9    Sugamura, K.10    Yarden, Y.11
  • 33
    • 0035831517 scopus 로고    scopus 로고
    • Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor
    • Chin LS, Raynor MC, Wei X, Chen HQ, Li L: Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor. J Biol Chem. 2001, 276: 7069-7078. 10.1074/jbc.M004129200.
    • (2001) J Biol Chem , vol.276 , pp. 7069-7078
    • Chin, L.S.1    Raynor, M.C.2    Wei, X.3    Chen, H.Q.4    Li, L.5
  • 34
    • 34248580495 scopus 로고    scopus 로고
    • Theoretical principles and practical considerations for fluorescence resonance energy transfer microscopy
    • Cardullo RA: Theoretical principles and practical considerations for fluorescence resonance energy transfer microscopy. Methods Cell Biol. 2007, 81: 479-494.
    • (2007) Methods Cell Biol , vol.81 , pp. 479-494
    • Cardullo, R.A.1
  • 35
    • 0031962107 scopus 로고    scopus 로고
    • Visualization of agonist-induced sequestration and down-regulation of a green fluorescent protein-tagged β2-adrenergic receptor
    • Kallal L, Gagnon AW, Penn RB, Benovic JL: Visualization of agonist-induced sequestration and down-regulation of a green fluorescent protein-tagged β2-adrenergic receptor. J Biol Chem. 1998, 273: 322-328. 10.1074/jbc.273.1.322.
    • (1998) J Biol Chem , vol.273 , pp. 322-328
    • Kallal, L.1    Gagnon, A.W.2    Penn, R.B.3    Benovic, J.L.4
  • 36
    • 0029752791 scopus 로고    scopus 로고
    • Endocytosis and molecular sorting
    • Mellman I: Endocytosis and molecular sorting. Annu Rev Cell Dev Biol. 1996, 12: 575-625. 10.1146/annurev.cellbio.12.1.575.
    • (1996) Annu Rev Cell Dev Biol , vol.12 , pp. 575-625
    • Mellman, I.1
  • 37
    • 0027534927 scopus 로고
    • Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification
    • Hansen SH, Sandvig K, van Deurs B: Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification. J Cell Biol. 1993, 121: 61-72. 10.1083/jcb.121.1.61.
    • (1993) J Cell Biol , vol.121 , pp. 61-72
    • Hansen, S.H.1    Sandvig, K.2    van Deurs, B.3
  • 39
    • 0034714283 scopus 로고    scopus 로고
    • Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation
    • Tikhomirov O, Carpenter G: Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation. J Biol Chem. 2000, 275: 26625-26631. 10.1074/jbc.M003114200.
    • (2000) J Biol Chem , vol.275 , pp. 26625-26631
    • Tikhomirov, O.1    Carpenter, G.2
  • 41
    • 62549147841 scopus 로고    scopus 로고
    • Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis
    • Ben-Kasus T, Schechter B, Lavi S, Yarden Y, Sela M: Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis. Proc Natl Acad Sci USA. 2009, 106: 3294-3299. 10.1073/pnas.0812059106.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 3294-3299
    • Ben-Kasus, T.1    Schechter, B.2    Lavi, S.3    Yarden, Y.4    Sela, M.5
  • 42
    • 31644439697 scopus 로고    scopus 로고
    • Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way
    • Lerdrup M, Hommelgaard AM, Grandal M, van Deurs B: Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way. J Cell Sci. 2006, 119: 85-95. 10.1242/jcs.02707.
    • (2006) J Cell Sci , vol.119 , pp. 85-95
    • Lerdrup, M.1    Hommelgaard, A.M.2    Grandal, M.3    van Deurs, B.4
  • 44
    • 55449129956 scopus 로고    scopus 로고
    • Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells
    • Barr DJ, Ostermeyer-Fay AG, Matundan RA, Brown DA: Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells. J Cell Sci. 2008, 121: 3155-3166. 10.1242/jcs.020404.
    • (2008) J Cell Sci , vol.121 , pp. 3155-3166
    • Barr, D.J.1    Ostermeyer-Fay, A.G.2    Matundan, R.A.3    Brown, D.A.4
  • 45
    • 77951757948 scopus 로고    scopus 로고
    • ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination
    • Marx C, Held JM, Gibson BW, Benz CC: ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination. Cancer Res. 2010, 70: 3709-3717. 10.1158/0008-5472.CAN-09-3768.
    • (2010) Cancer Res , vol.70 , pp. 3709-3717
    • Marx, C.1    Held, J.M.2    Gibson, B.W.3    Benz, C.C.4
  • 46
    • 33746012881 scopus 로고    scopus 로고
    • Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
    • Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, Verjee SS, Jones LA, Hershberg RM: Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol. 2006, 24: 3089-3094. 10.1200/JCO.2005.04.5252.
    • (2006) J Clin Oncol , vol.24 , pp. 3089-3094
    • Small, E.J.1    Schellhammer, P.F.2    Higano, C.S.3    Redfern, C.H.4    Nemunaitis, J.J.5    Valone, F.H.6    Verjee, S.S.7    Jones, L.A.8    Hershberg, R.M.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.